Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BWAY NASDAQ:NPCE NYSEAMERICAN:STXS OTCMKTS:WEDXF On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBWAYBrainsway$16.50+4.9%$15.01$5.68▼$17.35$631.24M1.2280,677 shs323,666 shsNPCENeuroPace$15.75-2.1%$16.19$7.56▼$19.60$548.23M1.88178,216 shs62,557 shsSTXSStereotaxis$1.50-3.2%$1.81$1.46▼$3.59$151.80M1.341.13 million shs1.81 million shsWEDXFWestaim$15.59-1.4%$16.41$14.37▼$22.26$525.86M0.213,539 shs2,850 shsThe 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBWAYBrainsway0.00%+4.45%+5.11%+0.32%+160.22%NPCENeuroPace0.00%-6.02%+2.88%-2.72%+77.48%STXSStereotaxis0.00%-8.82%-17.55%-21.72%-33.19%WEDXFWestaim0.00%-0.88%-1.50%-10.78%-27.84%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBWAYBrainsway$16.50+4.9%$15.01$5.68▼$17.35$631.24M1.2280,677 shs323,666 shsNPCENeuroPace$15.75-2.1%$16.19$7.56▼$19.60$548.23M1.88178,216 shs62,557 shsSTXSStereotaxis$1.50-3.2%$1.81$1.46▼$3.59$151.80M1.341.13 million shs1.81 million shsWEDXFWestaim$15.59-1.4%$16.41$14.37▼$22.26$525.86M0.213,539 shs2,850 shsThe 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBWAYBrainsway0.00%+4.45%+5.11%+0.32%+160.22%NPCENeuroPace0.00%-6.02%+2.88%-2.72%+77.48%STXSStereotaxis0.00%-8.82%-17.55%-21.72%-33.19%WEDXFWestaim0.00%-0.88%-1.50%-10.78%-27.84%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBWAYBrainsway 3.20Buy$15.67-5.05% DownsideNPCENeuroPace 2.88Moderate Buy$18.8319.58% UpsideSTXSStereotaxis 3.00Buy$3.88158.33% UpsideWEDXFWestaim 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest STXS, BWAY, NPCE, and WEDXF Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/20/2026BWAYBrainsway BTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$18.007/17/2026BWAYBrainsway HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$14.007/13/2026BWAYBrainsway Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Strong-Buy7/2/2026BWAYBrainsway HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$17.006/24/2026NPCENeuroPace Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)6/15/2026BWAYBrainsway HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$17.006/3/2026STXSStereotaxis CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingMarket Outperform5/26/2026BWAYBrainsway HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$15.00 ➝ $17.005/15/2026NPCENeuroPace HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$19.00 ➝ $20.005/13/2026STXSStereotaxis Piper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOverweight$4.00 ➝ $3.505/11/2026BWAYBrainsway Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold(Data available from 7/20/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBWAYBrainsway$52.22M12.68$0.25 per share67.19$1.87 per share8.82NPCENeuroPace$99.99M5.37N/AN/A$0.57 per share27.63STXSStereotaxis$32.38M4.54N/AN/A$0.14 per share10.71WEDXFWestaim$53.37M9.72N/AN/A$19.71 per share0.79Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBWAYBrainsway$7.57M$0.3547.1430.56N/A15.68%12.28%7.75%8/12/2026 (Estimated)NPCENeuroPace-$21.47M-$0.65N/AN/AN/A-21.67%-108.20%-18.50%8/11/2026 (Estimated)STXSStereotaxis-$21.64M-$0.28N/AN/AN/A-69.50%-163.30%-30.08%8/6/2026 (Estimated)WEDXFWestaim-$38M-$1.92N/AN/AN/A-108.56%-9.68%-7.67%8/18/2026 (Estimated)Latest STXS, BWAY, NPCE, and WEDXF EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/12/2026Q2 2026BWAYBrainsway$0.10N/AN/AN/A$16.50 millionN/A8/11/2026Q2 2026NPCENeuroPace-$0.19N/AN/AN/A$22.56 millionN/A8/6/2026Q2 2026STXSStereotaxis-$0.03N/AN/AN/A$8.35 millionN/A5/14/2026Q1 2026WEDXFWestaim-$0.33-$1.00-$0.67-$1.00$14.70 million$13.56 million5/13/2026Q1 2026BWAYBrainsway$0.05$0.12+$0.07$0.06$14.63 million$15.53 million5/12/2026Q1 2026NPCENeuroPace-$0.19-$0.13+$0.06-$0.20$21.65 million$22.00 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthBWAYBrainswayN/AN/AN/AN/AN/ANPCENeuroPaceN/AN/AN/AN/AN/ASTXSStereotaxisN/AN/AN/AN/AN/AWEDXFWestaim$0.090.58%N/AN/A N/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBWAYBrainswayN/A3.343.04NPCENeuroPace4.085.384.35STXSStereotaxisN/A1.561.11WEDXFWestaimN/A3.403.40Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBWAYBrainsway30.11%NPCENeuroPace78.83%STXSStereotaxis45.35%WEDXFWestaimN/AInsider OwnershipCompanyInsider OwnershipBWAYBrainsway19.00%NPCENeuroPace20.50%STXSStereotaxis16.03%WEDXFWestaim4.21%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBWAYBrainsway12040.13 million32.50 millionNot OptionableNPCENeuroPace17034.09 million27.11 millionOptionableSTXSStereotaxis13097.93 million82.24 millionNot OptionableWEDXFWestaim733.26 million31.86 millionNot OptionableSTXS, BWAY, NPCE, and WEDXF HeadlinesRecent News About These CompaniesWestaim (OTCMKTS:WEDXF) and Mativ (NYSE:MATV) Critical ReviewJuly 20 at 4:04 AM | americanbankingnews.comThe Westaim Corporation Announces Grants of Security-Based CompensationMay 20, 2026 | businesswire.comWestaim Reports Q1 2026 Results for the Quarter Ended March 31, 2026May 14, 2026 | businesswire.comWestaim Reports Q4 2025 Results For the Quarter and Year Ended December 31, 2025March 26, 2026 | businesswire.comThe Westaim Corporation Announces Board and Management Changes at Arena Investors Group Holdings, LLCMarch 12, 2026 | businesswire.comThe Westaim Corporation Announces Grants of Security-Based Compensation and Amendment to Long-Term Equity Incentive PlanDecember 29, 2025 | businesswire.comThe Westaim Corporation Announces Normal Course Issuer BidDecember 24, 2025 | businesswire.comThe Westaim Corporation Announces Andrew Rabinowitz Has Joined Arena Investors Group Holdings as President and General CounselNovember 24, 2025 | prnewswire.comWestaim Reports Q3 2025 Results for the Quarter Ended September 30, 2025November 13, 2025 | businesswire.comWestaim Reports Q2 2025 Results for the Quarter Ended June 30, 2025August 21, 2025 | businesswire.comAM Best Assigns Credit Ratings to Ceres Life Insurance CompanyJuly 15, 2025 | businesswire.comThe Westaim Corporation Reports Q1 2025 ResultsMay 14, 2025 | businesswire.comCC Capital and Westaim Complete Transaction, Creating Integrated Insurance and Asset Management PlatformApril 3, 2025 | businesswire.comWestaim Announces Receipt of Required Regulatory Approvals in Connection with CC Capital TransactionMarch 27, 2025 | businesswire.comThe Westaim Corporation Announces Normal Course Issuer BidMarch 26, 2025 | businesswire.comThe Westaim Corporation Reports Q4 and Full Year 2024 Results and Update on Timing of Proposed Transactions with CC CapitalMarch 26, 2025 | businesswire.comWestaim completes acquisition of ManhattanLifeFebruary 6, 2025 | insurancebusinessmag.comIWestaim: Transforming Into A Potential Long-Term Compounding MachineJanuary 30, 2025 | seekingalpha.comThe Westaim Corp WEDXDJanuary 14, 2025 | morningstar.comMThe Westaim Corporation Announces Completion of ArrangementJanuary 2, 2025 | businesswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeSTXS, BWAY, NPCE, and WEDXF Company DescriptionsBrainsway NASDAQ:BWAY$16.50 +0.77 (+4.90%) Closing price 04:00 PM EasternExtended Trading$16.66 +0.16 (+0.94%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. BrainsWay Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.NeuroPace NASDAQ:NPCE$15.75 -0.33 (-2.05%) Closing price 04:00 PM EasternExtended Trading$15.74 -0.02 (-0.10%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. It also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.Stereotaxis NYSEAMERICAN:STXS$1.50 -0.05 (-3.23%) Closing price 04:10 PM EasternExtended Trading$1.54 +0.04 (+2.40%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. The company provides Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and Stereotaxis Imaging Model S X-ray system, a single-plane, full-power x-ray system, including c-arm, powered table, motorized boom, and monitors for a robotic interventional operating room. In addition, it offers disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters. Further, the company provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. It markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with MAGiC catheter for cardiac ablation procedures. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.Westaim OTCMKTS:WEDXF$15.59 -0.22 (-1.39%) As of 03:29 PM EasternThe Westaim Corporation is a private equity firm specializing in direct and indirect investments through acquisitions, joint ventures, secondary investments both direct and indirect, fund of fund investments, and other arrangements. For direct investments, the firm invests in early venture, mid venture, late venture, middle market, later stage, mature, emerging growth, PIPEs, and buyout transactions. For fund of fund investments, it seeks to invest in private equity funds, venture capital funds, and hedge funds. The firm seeks to provide long term capital to businesses operating in the global financial services industry. It typically acquires controlling interests in businesses. The firm seeks to acquire debt, equity, or derivative securities of both public and private companies. It invests with the objective of providing its shareholders with capital appreciation and real wealth preservation. The firm seeks to provide its portfolio companies with advisory services including, but not limited to, advice on capital allocation, financing strategy, performance measurement and merger and acquisition support. It also seeks to partner with like-minded providers of third party capital to help supplement the firm's own capital, when completing acquisitions. The firm generally seeks to hold its investments for seven to 15 years. The Westaim Corporation was founded in 1996 and is based in Toronto, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino's Stock Serving Up a Buying Opportunity? AI Data Centers Need Power, and These 2 Industrials Are Cashing In 5 Stocks Quietly Trading Near All-Time Highs While Everyone Watches the AI Drama Meta Platforms Turns AI Power Scarcity Into a $10 Billion Cloud Bet Why Gold Miners Could Be the Market's Biggest Comeback Story A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Amazon’s AI Spending Is About to Face Its Most Important AWS Test Yet Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
